U.S. federal trademark · Serial No. 78419326 · Reg. No. 3584518
Antibodies for pharmaceutical and therapeutic treatment of cancer, inflammatory disorders, infectious diseases, organ rejection, cardiac complications, tissue degeneration or damage, metabolic disorders and genetic disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.